Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan G Pol

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Biomedicines|March 25, 2022
Circular RNAs as Potential Biomarkers in Breast CancerFatima Domenica Elisa De Palma, Francesco Salvatore, Jonathan G Pol, et al.
Cancer Immunology Research|April 30, 2014
Combining oncolytic HSV-1 with immunogenic cell death-inducing drug mitoxantrone breaks cancer immune tolerance and improves therapeutic efficacySamuel T Workenhe, Jonathan G Pol, Brian D Lichty, et al.
Seminars in Immunology|September 30, 2025
Latest insights into oncolytic viro-immunotherapy with vesicular stomatitis virusManuela Lizarralde-Guerrero, David Olagnier, Fernando Aranda, et al.
Cancers|December 11, 2022
Systematic Investigation of the Diagnostic and Prognostic Impact of LINC01087 in Human CancersFatima Domenica Elisa De Palma, Vincent Carbonnier, Francesco Salvatore, et al.
Nature Protocols|May 20, 2024
Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapyShashi Gujar, Jonathan G Pol, Vishnupriyan Kumar, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 18, 2013
Immunogenic HSV-mediated oncolysis shapes the antitumor immune response and contributes to therapeutic efficacySamuel T Workenhe, Graydon Simmons, Jonathan G Pol, et al.
Journal for Immunotherapy of Cancer|June 3, 2026
Repurposing COVID-19 (and other) mRNA vaccines to boost cancer immunotherapy efficacy: mechanistic insights and future directionsShashi Gujar, Jonathan G Pol, Vishnu Vijay Vijayan, et al.
Methodsx|March 4, 2022
Improved Swiss-rolling method for histological analyses of colon tissueJulie Le Naour, Léa Montégut, Adrien Joseph, et al.
Frontiers in Physiology|December 7, 2020
Dynamical Boolean Modeling of Immunogenic Cell DeathAndrea Checcoli, Jonathan G Pol, Aurelien Naldi, et al.
Oncoimmunology|December 7, 2017
Trial watch: DNA-based vaccines for oncological indicationsStefano Pierini, Renzo Perales-Linares, Mireia Uribe-Herranz, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Biomedicines|March 25, 2022
Circular RNAs as Potential Biomarkers in Breast CancerFatima Domenica Elisa De Palma, Francesco Salvatore, Jonathan G Pol, et al.
Cancer Immunology Research|April 30, 2014
Combining oncolytic HSV-1 with immunogenic cell death-inducing drug mitoxantrone breaks cancer immune tolerance and improves therapeutic efficacySamuel T Workenhe, Jonathan G Pol, Brian D Lichty, et al.
Seminars in Immunology|September 30, 2025
Latest insights into oncolytic viro-immunotherapy with vesicular stomatitis virusManuela Lizarralde-Guerrero, David Olagnier, Fernando Aranda, et al.
Cancers|December 11, 2022
Systematic Investigation of the Diagnostic and Prognostic Impact of LINC01087 in Human CancersFatima Domenica Elisa De Palma, Vincent Carbonnier, Francesco Salvatore, et al.
Nature Protocols|May 20, 2024
Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapyShashi Gujar, Jonathan G Pol, Vishnupriyan Kumar, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 18, 2013
Immunogenic HSV-mediated oncolysis shapes the antitumor immune response and contributes to therapeutic efficacySamuel T Workenhe, Graydon Simmons, Jonathan G Pol, et al.
Journal for Immunotherapy of Cancer|June 3, 2026
Repurposing COVID-19 (and other) mRNA vaccines to boost cancer immunotherapy efficacy: mechanistic insights and future directionsShashi Gujar, Jonathan G Pol, Vishnu Vijay Vijayan, et al.
Methodsx|March 4, 2022
Improved Swiss-rolling method for histological analyses of colon tissueJulie Le Naour, Léa Montégut, Adrien Joseph, et al.
Frontiers in Physiology|December 7, 2020
Dynamical Boolean Modeling of Immunogenic Cell DeathAndrea Checcoli, Jonathan G Pol, Aurelien Naldi, et al.
Oncoimmunology|December 7, 2017
Trial watch: DNA-based vaccines for oncological indicationsStefano Pierini, Renzo Perales-Linares, Mireia Uribe-Herranz, et al.
Pageof 6